Pulmonary Vascular Disease News

For patients with suspected pulmonary embolism, diagnostic strategies to rule out PE that apply adapted D-dimer thresholds were safe and efficient, even in high-risk patients.

Results of a 5-year study in Japan suggest pulmonary embolism may be a major cause of sudden cardiac arrest among patients with psychiatric disorders.

In this episode, Joel M. Gelfand, MD, MSCE, and Leonard H. Calabrese, DO, are joined by Paul E. Sax, MD, as they discuss advances in the outpatient management of COVID-19 and emerging information about the omicron variant.

In this video, Philip J. Landrigan, MD, MSc, FAAP, highlights key points from his review article about the impact of pollution on cardiovascular health. The article was published in the New England Journal of Medicine.

The Pulmonary Embolism Syncope-Anemia-Renal Dysfunction risk score was successful in estimating risk for early major bleeding in patients with acute pulmonary embolism, according to new research published in Chest.

In patients hospitalized with COPD exacerbations, those who received usual care plus an active strategy for diagnosing pulmonary embolism did not have improved outcomes compared with those who received usual care only.

Chimeric antigen receptor T-cell therapy appeared associated with various cardiovascular and pulmonary adverse events, according to results of a retrospective pharmacovigilance study.

As understanding of pulmonary arterial hypertension grows and novel therapies emerge, the treatment of PAH appears to be entering a new era.

Due to nonspecific symptoms and a wide variety of therapeutic options, diagnosis and treatment of pulmonary embolism can be challenging.

The REVEAL Lite 2 risk assessment tool is prognostic of long-term outcomes in patients with pulmonary arterial hypertension and also detected response to treatment, a presenter said at the CHEST Annual Meeting.